Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

It does nothing for your credibility here given that you won't have a conversation and discuss negatives about a company, you only want to focus on the positives... but lets be real... lots of red flags

1) Starting a new research program before the last open trial hasn't released data yet! Classic move. Pump up the SP before dropping the bad news. Try to get excited about a phase 1 DMT study... it would be YEARS before ever getting to a phase 3, and most phase 1 flop... that's proven...
2) Execs paying themselves monster salaries with NO revenues.
3) Delays upon delays in delivering data...
4) Mark Williams working on another company... so is Kal!
5) Increasing the number of individuals in the preliminary trial results that flopped, in an effort to improve the statistical power to search for signal. I mean these guys literally included extra patients in the early data reading because they found nothing with fewer numbers... so FOR AMG/MONEY SHOT: THE SCIENCE FAILED
6)dilution upon dilution and Kal insider trading.
7) news releases every other day with no real material reporting just pumping